Clinical Trials Logo

IUGR clinical trials

View clinical trials related to IUGR.

Filter by:

NCT ID: NCT02813525 Not yet recruiting - IUGR Clinical Trials

Ultrasound Monitoring of Fetuses With Vascular Intra-uterine Growth Restriction (IUGR) Using the Isthmus Systolic Index (ISI): Feasibility, Comparison to Normal Fetuses and Association With Perinatal Mortality

f-ISI-RCIU
Start date: September 2016
Phase: N/A
Study type: Observational

Fetuses with IUGR, there is a correlation between Doppler indices of cardiovascular function and perinatal mortality. An index of systolic flow velocities at the aortic isthmus (ISI) has previously been described in a population of normal fetuses. Fetuses with IUGR, the velocities recorded in the aortic isthmus could be affected and the normal development of the ISI should be changed, because of the increase in placental resistance on one hand, and the gradual deterioration ventricular functions on the other one. Investigators hypothesize that the ISI index in the context of placental insufficiency could provide additional arguments on the extraction timing, the prognosis and the fetal extraction mode to severe hypoxia. The primary outcome of the study is to evaluate in an exploratory manner the feasibility and the potential interest of longitudinal monitoring of fetuses with IUGR by Doppler systolic isthmus and the calculation of the ISI index.

NCT ID: NCT02738463 Active, not recruiting - IUGR Clinical Trials

Maternal Serum Ferritin and Low Neonatal Birth Weight

LBW
Start date: March 2016
Phase: N/A
Study type: Observational [Patient Registry]

Intrauterine growth restriction ( IUGR )is defined as fetal growth slower than the normal growth potential of a specific fetus because of genetic or environmental factors. Recently several studies have highlighted the role of many biomolecules as markers for IUGR. Measurement of maternal serum ferritin has also been used as a predictive marker for increased risk of IUGR. Iron deficiency has its known deleterious effect in pregnancy but iron loading may be associated with oxidative damage to cells and tissues. It has been shown in various studies that lower level of transferritin receptor expression in placenta is associated with preeclampsia and IUGR. This can lead to decrease extraction of iron by placenta from maternal serum leading to increase maternal serum ferritin. This fetal iron deficiency leads to increase in fetal corticotropins and fetal cortisol, causing inhibition of fetal growth

NCT ID: NCT02583763 Active, not recruiting - Clinical trials for Fetal Growth Retardation

Cardiac Displacement From Third Trimester to Early Childhood

CADETTE
Start date: January 2013
Phase:
Study type: Observational [Patient Registry]

The aim is to increase awareness of the relationship between (IUGR) and cardiac function in the foetus, the development of cardiac function over time after delivery and what significance a possible early disturbed myocardial function have for the neonate and the child during the first years of life.

NCT ID: NCT02541110 Not yet recruiting - Preeclampsia Clinical Trials

Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler

Start date: September 2015
Phase: N/A
Study type: Observational

Second trimester homocysteine & uterine artery doppler will be assessed& the cases will be followed up till delivery for development of preeclampsia, IUGR(intra-uterine growth retardation) & other obstetric complications.

NCT ID: NCT02397291 Terminated - Pregnancy Clinical Trials

Transplacental Gradients and Transport in Intrauterine Growth Restricted (IUGR) Pregnancies Compared to Normal Pregnancies.

Start date: January 2001
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the transplacental gradients for 6 polyols and mannose are altered in intrauterine growth restricted (IUGR) pregnancies compared to normal pregnancies and b) to determine the relative contributions of transplacental transport vs production by the conceptus of both inositol (the major polyol) and mannose in IUGR and normal pregnancies using stable isotopic methodology.

NCT ID: NCT02391519 Recruiting - Pregnancy Clinical Trials

Effects of High Altitude on AMPK Activation

Start date: January 2016
Phase:
Study type: Observational

Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA). If altered MA vasoreactivity is found, further studies may be able to link these changes to the increased rates of PreE and IUGR at altitude and contribute to the understanding of these two disorders.

NCT ID: NCT02382601 Recruiting - Pregnancy Clinical Trials

Longitudinal Study of Intra-Uterine Growth Restriction

Start date: April 2015
Phase:
Study type: Observational

The investigation will employ a longitudinal approach in which every fetus diagnosed to be SGA (Small for Gestational Age ) will be studied at frequent intervals with sophisticated imaging techniques to assess subtle physiologic changes in the brain, heart, and placenta over time. These findings will be correlated with neurological and cardiovascular function in the newborn and early childhood. This research initiative should yield diagnostic and therapeutic templates that will improve the quality of life of IUGR babies in addition to providing important information that will better inform current diagnostic practices.

NCT ID: NCT01669525 Completed - Pre-Eclampsia Clinical Trials

Placental Growth and Adverse Pregnancy Outcomes

Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of this study to determine if measurement of maternal serum biomarkers and evaluation of the placenta by ultrasound can improve prediction of adverse pregnancy outcomes.

NCT ID: NCT00634855 Terminated - Preeclampsia Clinical Trials

Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR

Start date: March 2008
Phase:
Study type: Observational

The objective of this study is to determine whether there are alterations in the population of endothelial progenitor cells in umbilical cord blood samples of infants born in the setting of maternal preeclampsia or fetal growth restriction.

NCT ID: NCT00347867 Not yet recruiting - IUGR Clinical Trials

Viagra for the Treatment of IUGR

Start date: July 2006
Phase: Phase 4
Study type: Interventional

It has been suggested that Viagra (or other drugs that inhibit PDE-5, the enzyme that normally inhibits blood vessels’ ability to expand) may have beneficial effects in hypertensive pregnancy and, possibly, preeclampsia.The benefits of Viagra were observed without any reduction in maternal blood pressure, thereby dissociating hypertension per se from the loss of NO (nitrous oxide) signaling in the uterine circulation.Following publications, suggesting that sildenafil citrate used as a therapeutic agent may improve myometrial perfusion in IUGR gestations by promoting myometrial small artery vasodilatation, decreasing peripheral resistance and increasing flow within the uteroplacental bed, we intend to administer this medication to parturients where intauterine growth restriction and pregnancy associated hypertension have been diagnosed in an attempt to induce vasodilatation and improved uteroplacental perfusion resulting in improved fetal growth.